Takehiko Manabe
Kitakyushu, 8078556, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Lessons from surgery after neoadjuvant chemoimmunotherapy for bulky, invasive N2 lung cancer: a case report.
Journal: General thoracic and cardiovascular surgery cases
Published: July 05, 2026
Preoperative and Intraoperative Localization of Small Pulmonary Nodules for Sublobar Resection: Practical Insights into Percutaneous, Bronchoscopic/Robotic, RFID (SuReFInD), and Hybrid-OR CT Workflows.
Journal: Diseases (Basel, Switzerland)
Published: April 15, 2026
Impact of CD73/CD155 Expression on Survival in Resected Epithelial Pleural Mesothelioma: A Retrospective Single-center Study.
Journal: In vivo (Athens, Greece)
Published: March 04, 2026
Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective Study.
Journal: Annals of surgical oncology
Published: December 17, 2025
PD-L1 expression as a prognostic factor for postoperative outcomes in pleural mesothelioma.
Journal: Translational lung cancer research
Published: May 25, 2025
Real-world insights into atezolizumab plus bevacizumab, carboplatin, and paclitaxel for advanced non-squamous non-small cell lung cancer.
Journal: Translational lung cancer research
Published: April 28, 2025
Surgical indications for pleurectomy/decortication in pleural mesothelioma based on the newly revised 9th edition of the tumour-node-metastasis classification.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: October 21, 2024
Immune checkpoint inhibitors in the treatment of pleural mesothelioma: insights from real-world data.
Journal: International journal of clinical oncology
Published: August 31, 2024
Enhanced capture system for mesenchymal‑type circulating tumor cells using a polymeric microfluidic device 'CTC‑Chip' incorporating cell‑surface vimentin.
Journal: Oncology reports
Published: May 20, 2024
A case of salvage surgery following chemoradiotherapy and durvalumab for initially unresectable superior sulcus tumor with N3 involvement.
Journal: General thoracic and cardiovascular surgery cases
Published: April 21, 2024
Last Updated: 09/26/2026